Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME. Barnett AH, et al. Among authors: kendall dm. Clin Ther. 2007 Nov;29(11):2333-48. doi: 10.1016/j.clinthera.2007.11.006. Clin Ther. 2007. PMID: 18158075 Clinical Trial.
Exenatide once weekly for the treatment of type 2 diabetes.
Malone J, Trautmann M, Wilhelm K, Taylor K, Kendall DM. Malone J, et al. Among authors: kendall dm. Expert Opin Investig Drugs. 2009 Mar;18(3):359-67. doi: 10.1517/13543780902766802. Expert Opin Investig Drugs. 2009. PMID: 19243286 Review.
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Kendall DM, Rubin CJ, Mohideen P, Ledeine JM, Belder R, Gross J, Norwood P, O'Mahony M, Sall K, Sloan G, Roberts A, Fiedorek FT, DeFronzo RA. Kendall DM, et al. Diabetes Care. 2006 May;29(5):1016-23. doi: 10.2337/diacare.2951016. Diabetes Care. 2006. PMID: 16644631 Clinical Trial.
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Bunck MC, Diamant M, Cornér A, Eliasson B, Malloy JL, Shaginian RM, Deng W, Kendall DM, Taskinen MR, Smith U, Yki-Järvinen H, Heine RJ. Bunck MC, et al. Among authors: kendall dm. Diabetes Care. 2009 May;32(5):762-8. doi: 10.2337/dc08-1797. Epub 2009 Feb 5. Diabetes Care. 2009. PMID: 19196887 Free PMC article. Clinical Trial.
137 results